Privia Health Group, Inc.
PRVA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,736,390 | $1,657,737 | $1,356,660 | $966,220 |
| % Growth | 4.7% | 22.2% | 40.4% | – |
| Cost of Goods Sold | $1,559,537 | $1,496,236 | $1,221,878 | $902,558 |
| Gross Profit | $176,853 | $161,501 | $134,782 | $63,662 |
| % Margin | 10.2% | 9.7% | 9.9% | 6.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $126,157 | $109,587 | $129,592 | $255,884 |
| SG&A Expenses | $152,603 | $134,319 | $149,333 | $278,634 |
| Sales & Mktg Exp. | $26,446 | $24,732 | $19,741 | $22,750 |
| Other Operating Expenses | $7,268 | $6,533 | $4,571 | $2,464 |
| Operating Expenses | $159,871 | $140,852 | $153,904 | $281,098 |
| Operating Income | $16,982 | $20,649 | -$19,122 | -$217,436 |
| % Margin | 1% | 1.2% | -1.4% | -22.5% |
| Other Income/Exp. Net | $10,888 | $8,372 | $542 | -$1,070 |
| Pre-Tax Income | $27,870 | $29,021 | -$18,580 | -$218,506 |
| Tax Expense | $10,826 | $7,993 | -$6,516 | -$27,857 |
| Net Income | $14,385 | $23,079 | -$8,585 | -$188,230 |
| % Margin | 0.8% | 1.4% | -0.6% | -19.5% |
| EPS | 0.12 | 0.2 | -0.11 | -1.77 |
| % Growth | -40% | 281.8% | 93.8% | – |
| EPS Diluted | 0.11 | 0.19 | -0.11 | -1.77 |
| Weighted Avg Shares Out | 119,403 | 116,731 | 110,695 | 107,838 |
| Weighted Avg Shares Out Dil | 125,614 | 124,686 | 110,695 | 107,838 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10,888 | $8,372 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1,070 |
| Depreciation & Amortization | $7,268 | $6,533 | $4,571 | $2,464 |
| EBITDA | $24,250 | $27,182 | -$14,551 | -$214,972 |
| % Margin | 1.4% | 1.6% | -1.1% | -22.2% |